LONDON, April 29, 2005 (PRIMEZONE) -- Cancer drug developer Antisoma plc (LSE:ASM) today announces that its Chief Executive Officer, Glyn Edwards, will be presenting at the Rodman & Renshaw Annual Global Healthcare Conference in Paris on Wednesday 4 May.
Mr Edwards's presentation will take place at 12.20pm CET (6.20am EST). A live webcast of the presentation will be available to all parties on Antisoma's website www.antisoma.com
It is recommended that viewers log on 15 minutes early in order to register and download any necessary software. If you are unable to participate during the live web cast, a recorded replay of the presentation will be available for 90 days.
Background on Antisoma
Antisoma is a biopharmaceutical company that develops novel products for the treatment of cancer. Antisoma fills its development pipeline by acquiring promising new product candidates from internationally recognised academic or cancer research institutions. Its core activity is the preclinical and clinical development of these drug candidates. In November 2002, Antisoma formed a broad strategic alliance with Roche to develop and commercialise products from Antisoma's pipeline. Please visit www.antisoma.com for further information.